New eye drops zap allergy itch in just minutes
NCT ID NCT05234554
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an eye drop called reproxalap in 131 adults with moderate-to-severe seasonal eye allergies. Participants were exposed to ragweed pollen in a special chamber to trigger symptoms. The eye drop was compared to a placebo (no active ingredient) to see if it reduced itching and redness. Results showed reproxalap helped relieve symptoms better than the placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research
Mississauga, Ontario, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental antibodies aim to block cat allergy eye itch
- Eye insert could ease allergy symptoms for contact lens wearers
- Which eye drop stings less? small study pits flarex against lotemax SM
- Scientists hunt for eye disease clues in your tears
- Can ectoin sprays and drops soothe hay fever? new study investigates
- Can allergy shots work as well for kids as adults? new study aims to find out.